Summit Technology seeks patent extension for excimer laser:
This article was originally published in Clinica
Executive Summary
Summit Technology is seeking 609 days' US patent extension for its Excimed UV200LA/SVS Apex Excimer Laser System which was approved in March this year for phototherapeutic keratectomy procedures. The US FDA has determined that the regulatory review period was 2,271 days, of which 1,156 occurred during the testing phase and 1,115 during the approval phase.
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.